LYS006
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LYS006, covering 2023-03-20 to 2023-11-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis [Phase 2]